Atypical Hemolytic Uremic Syndrome Caused by a Rare Complement Factor B Mutation.
atypical hus
complement factor b
complement-mediated
hemolytic uremic syndrome
thrombotic microangiopathy (tma)
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
accepted:
15
03
2022
entrez:
23
3
2022
pubmed:
24
3
2022
medline:
24
3
2022
Statut:
epublish
Résumé
Thrombotic microangiopathy (TMA), a rare and diagnostically challenging condition, commonly presents with a triad of thrombocytopenia, hemolytic anemia, and end-organ damage, such as renal failure. Most cases of the hemolytic uremic syndrome (HUS) are mediated by Shiga toxin-producing
Identifiants
pubmed: 35317246
doi: 10.7759/cureus.23207
pmc: PMC8934198
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e23207Informations de copyright
Copyright © 2022, Bandaru et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2009 Jan 29;360(5):542-4
pubmed: 19179328
J Am Soc Nephrol. 2005 Apr;16(4):1035-50
pubmed: 15728781
Medicine (Baltimore). 2021 Mar 19;100(11):e25069
pubmed: 33725982
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):240-5
pubmed: 17182750
Clin Kidney J. 2017 Oct;10(5):600-624
pubmed: 28980670
Pediatr Nephrol. 2008 Nov;23(11):1957-72
pubmed: 18594873
Curr Opin Nephrol Hypertens. 2010 May;19(3):242-7
pubmed: 20186056
Blood. 2010 Jan 14;115(2):379-87
pubmed: 19861685
J Nephrol. 2017 Jun;30(3):347-362
pubmed: 27848226
N Engl J Med. 2011 Jun 30;364(26):2561-3
pubmed: 21612462
Am J Nephrol. 2016;43(3):160-9
pubmed: 27064621
Kidney Int Rep. 2021 Jan;6(1):11-23
pubmed: 33102952